Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Healius Ltd

Healthcare AU HLS

0.32AUD
0.00(0%)

Last update at 2026-06-05T00:55:00Z

Day Range

0.320.33
LowHigh

52 Week Range

0.341.07
LowHigh

Fundamentals

  • Previous Close 0.32
  • Market Cap250.52M
  • Volume379836
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA41.20M
  • Revenue TTM1370.00M
  • Revenue Per Share TTM1.87
  • Gross Profit TTM 414.40M
  • Diluted EPS TTM-0.76

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax -592.10000M -650.10000M -397.30000M 416.90M 167.80M
Minority interest - - - - -
Net income -151.20000M -645.80000M -367.80000M 307.90M 43.70M
Selling general administrative 35.80M 931.40M 864.30M 951.40M 856.30M
Selling and marketing expenses 24.40M 25.70M - - -
Gross profit 398.60M 1521.90M 1483.20M 2019.50M 1630.10M
Reconciled depreciation 224.30M 281.20M 277.20M 278.50M 247.30M
Ebit 0.20M -579.30000M 34.10M 432.40M 221.40M
Ebitda 31.20M -298.10000M 311.30M 710.90M 468.70M
Depreciation and amortization 31.00M 281.20M 277.20M 278.50M 247.30M
Non operating income net other - - - - -
Operating income 0.20M 65.50M 98.10M 484.40M 270.80M
Other operating expenses 1005.80M 1680.70M 263.30M 775.30M 672.60M
Interest expense 65.10M 70.80M 28.60M 15.50M 53.60M
Tax provision -29.10000M -14.10000M -17.30000M 122.90M 101.50M
Interest income 65.10M 70.80M 62.30M 50.50M 62.90M
Net interest income -65.10000M -70.80000M -62.30000M -50.50000M -87.60000M
Extraordinary items 411.80M -9.80000M 12.20M 13.90M -22.60000M
Non recurring - - - - -
Other items - - - - -
Income tax expense 29.10M -14.10000M -17.30000M 122.90M 101.50M
Total revenue 1344.20M 1746.20M 1706.90M 2336.20M 1900.70M
Total operating expenses 60.20M 1456.40M 1385.10M 1531.60M 1388.20M
Cost of revenue 945.60M 224.30M 223.70M 316.70M 270.60M
Total other income expense net -592.30000M -715.60000M -433.10000M -20.50000M 13.50M
Discontinued operations - - 12.20M 13.90M -22.60000M
Net income from continuing ops -563.00000M -636.00000M -380.00000M 294.00M 66.30M
Net income applicable to common shares -151.20000M -645.80000M -367.80000M 307.90M 43.70M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 1777.00M 2982.80M 3653.20M 4136.80M 3782.20M
Intangible assets 56.60M - 73.10M 75.20M 76.30M
Earning assets - - - - -
Other current assets - 20.40M 31.60M 70.80M 40.80M
Total liab 1189.10M 1942.10M 2147.00M 2215.20M 1924.90M
Total stockholder equity 587.90M 1040.70M 1506.20M 1921.60M 1857.30M
Deferred long term liab - - - - -
Other current liab - 128.10M 0.90M 5.70M 52.30M
Common stock - 2603.90M 2421.00M 2422.90M 2572.00M
Capital stock 2604.00M - 2421.00M 2422.90M 2572.00M
Retained earnings -2016.40000M -1567.30000M -923.30000M -521.20000M -731.60000M
Other liab - - 14.40M 18.60M 22.50M
Good will 430.00M 1296.70M 1897.50M 2344.30M 2042.30M
Other assets - - 87.90M 74.60M 82.20M
Cash 57.20M 60.10M 115.30M 81.30M 70.10M
Cash and equivalents - - - - -
Total current liabilities 446.20M 600.30M 629.60M 641.30M 684.70M
Current deferred revenue - 0.00000M 147.70M 242.30M 196.50M
Net debt - 1537.80M 1650.70M 1697.70M 1372.00M
Short term debt - 271.30M 263.00M 223.70M 230.00M
Short long term debt - - - - 5.60M
Short long term debt total - 1597.90M 1766.00M 1779.00M 1442.10M
Other stockholder equity - -0.90000M -1497.70000M -1901.70000M -1844.00000M
Property plant equipment - - 1243.30M 1270.90M 1244.90M
Total current assets 251.90M 300.10M 344.30M 371.80M 330.90M
Long term investments - - 7.10M 5.80M 5.60M
Net tangible assets - - -464.40000M -497.90000M -261.30000M
Short term investments - - - - -
Net receivables 128.30M 187.70M 164.60M 219.70M 184.10M
Long term debt - - 562.10M 606.10M 258.10M
Inventory 29.80M 31.90M 32.80M 49.20M 35.90M
Accounts payable 133.90M 200.90M 218.00M 169.60M 205.90M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 5.00M 8.50M 19.90M 16.90M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -3.60000M
Accumulated amortization - - - - -
Non currrent assets other - 71.80M - - -
Deferred long term asset charges - - - - -
Non current assets total 1525.10M 2682.70M 3308.90M 3765.00M 3451.30M
Capital lease obligations 911.80M - 1203.90M 1172.90M 1177.60M
Long term debt total - - 1503.00M 1555.30M 1211.30M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments 730.00M -63.00000M 67.30M -401.70000M 386.90M
Change to liabilities - - 44.80M -33.60000M -57.60000M
Total cashflows from investing activities 730.00M -63.00000M 67.30M -401.70000M 386.90M
Net borrowings -426.10000M -142.50000M -261.80000M 131.10M -758.80000M
Total cash from financing activities -1018.60000M -259.00000M -366.60000M -176.50000M -984.70000M
Change to operating activities - - -31.60000M 2.50M 34.40M
Net income -151.20000M -636.00000M -367.80000M 307.90M 43.70M
Change in cash -2.90000M -55.20000M 34.00M 8.60M -71.80000M
Begin period cash flow 60.10M 115.30M 81.30M 72.70M 144.50M
End period cash flow 57.20M 60.10M 115.30M 81.30M 72.70M
Total cash from operating activities 285.70M 266.80M 333.30M 586.80M 525.90M
Issuance of capital stock - 179.30M - - -
Depreciation 238.80M 281.20M 262.60M 265.00M 237.00M
Other cashflows from investing activities 784.80M -11.00000M 143.40M -308.20000M -10.00000M
Dividends paid -299.90000M - 34.30M 98.10M 56.30M
Change to inventory -0.90000M 0.90M 14.50M -12.40000M -8.90000M
Change to account receivables 14.90M -21.20000M 52.60M -33.00000M 46.10M
Sale purchase of stock 0.00000M 179.30M -8.90000M -139.40000M -97.50000M
Other cashflows from financing activities -73.10000M -295.80000M -278.40000M 61.00M -242.00000M
Change to netincome - - 431.80M 40.30M 127.20M
Capital expenditures 54.00M 64.00M 76.10M 93.50M 61.30M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 17.00M -38.70000M 67.10M -45.40000M 37.20M
Stock based compensation 0.10M 0.40M -7.80000M 7.90M 13.70M
Other non cash items 181.00M 660.30M 438.50M 13.90M 245.20M
Free cash flow 231.70M 173.80M 257.20M 493.30M 464.60M

Peer Comparison

Sector: Healthcare Industry: Diagnostics & Research

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
HLS
Healius Ltd		 - -% 0.32 - 29.24 0.18 0.46 0.83 10.14
SHL
Sonic Healthcare Ltd		 0.12 0.63% 19.18 16.95 13.83 0.89 1.09 1.42 8.36
IDX
Integral Diagnostics Ltd		 - -% 2.03 53.00 13.87 1.03 1.14 1.75 11.21
ACL
Australian Clinical Labs Ltd		 0.03 1.47% 2.07 14.18 11.16 0.51 2.50 0.92 3.72
MVF
Monash Ivf Group Ltd		 0.005 0.72% 0.70 17.75 13.93 1.03 1.09 1.73 9.15

Reports Covered

Stock Research & News

View All

Profile

Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories and patient collection centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.

Healius Ltd

161 Castlereagh Street, Sydney, NSW, Australia, 2000

Key Executives

Name Title Year Born
Dr. Malcolm W. Parmenter B.S., M.A.I.C.D., M.S. MD, CEO & Director 1955
Ms. Maxine Jaquet CFO & COO NA
Mr. John McKechnie Chief Exec. of the Pathology Division NA
Mr. Rob Phipps Group Exec. of People & Culture and Sustainability NA
Mr. Henry Barclay Chief Exec. of Day Hospitals NA
Mr. Charles Tilley B.Sc., FCIS, L.L.B., B.Sc. (Hons), LLB (Hons) Company Sec. NA
Ms. Alison Stephenson Additional Company Sec. NA
Ms. Janet Payne Group Exec. of Corp. Affairs NA
Dr. John Houston Advisor NA
Ms. Maxine Jaquet B.Com. MD, CEO & Director NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.